ROS-ACTIVATED COMPOUNDS AS SELECTIVE ANTI-CANCER THERAPEUTICS
申请人:University Of Cincinnati
公开号:EP2819993B1
公开(公告)日:2020-09-02
US9394233B2
申请人:——
公开号:US9394233B2
公开(公告)日:2016-07-19
ROS-Activated Compounds as Selective Anti-Cancer Therapeutics
申请人:UNIVERSITY OF CINCINNATI
公开号:US20130230542A1
公开(公告)日:2013-09-05
Provided are compounds according to the following Formula I:
The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer therapeutics for cancers associated with elevated ROS. Also provided are methods and pharmaceutical compositions for treating cancers associated with increased ROS.